TNF-α inhibitors, which neutralize the activity of TNF-α, have traditionally been reserved for pregnant women with autoimmune conditions such as rheumatoid arthritis (RA) or inflammatory bowel disease (IBD) [122]. Here, TNF is linked to Autoimmunity.